<Disease><Name>AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADC)</Name><Synonym>AROMATIC L-AMINO ACID DECARBOXYLASE; DOPA DECARBOXYLASE; DDC</Synonym><OMIM><Number>608643</Number><URL>http://omim.org/entry/608643</URL></OMIM><Orphanet><Number>35708</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=35708</URL></Orphanet><Protein><Number>Aromatic-L-amino-acid decarboxylase</Number><URL>http://www.uniprot.org/uniprot/P20711</URL></Protein><ExPASy><Number>4.1.1.28</Number><URL>http://enzyme.expasy.org/EC/4.1.1.28</URL></ExPASy><Gene>7p12.2-p12.1</Gene><ICD>G24.8</ICD><Summary>rare (~100 patients);autosomal recessive;mutation in the AADC gene</Summary><Symptoms><symtomp><id>3424</id><symptom>abnormal movement</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2267</id><symptom>Amino acid, spinal fluid</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2088</id><symptom>Amino acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2241</id><symptom>athetosis</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1983</id><symptom>constipation</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3624</id><symptom>diurnal fluctuation of symptom</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3982</id><symptom>drooling</symptom><category>HEAD</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1724</id><symptom>eye movements, abnormal</symptom><category>EYES</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3627</id><symptom>hypokinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2166</id><symptom>hypotension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2094</id><symptom>hypothermia</symptom><category>ENDOCRINE SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1715</id><symptom>infections (severe or recurrent)</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3960</id><symptom>movement disorder, hyperkinetic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2513</id><symptom>oculogyric crisis</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2266</id><symptom>Organic acid, spinal fluid</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2379</id><symptom>pallor</symptom><category>SKIN</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1934</id><symptom>sweating</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>3315</id><symptom>temperature instability</symptom><category>GENERAL TOPICS | GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1779</id><name>N-Acetyltyrosine</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>1100.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1878</id><name>Vanillic acid</name><specimen>urine</specimen><value>increased</value><min>0.60</min><max>3.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2096</id><name>3-O-methyldopa</name><specimen>urine</specimen><value>increased</value><min>152.00</min><max>378.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>2128</id><name>3-Methoxytyramine</name><specimen>urine</specimen><value>increased</value><min>45.00</min><max>480.00</max><unit>&#181;mol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>2129</id><name>3-Methoxytyramine</name><specimen>urine</specimen><value>increased</value><min>60.00</min><max>145.00</max><unit>&#956;mol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>914</id><name>3-Methoxytyrosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>907</id><name>3-Methoxytyrosine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>&#956;mol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>915</id><name>3-Methoxytyrosine</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>916</id><name>5-Hydroxytryptophan</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>908</id><name>5-Hydroxytryptophan</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit /><age>no data</age><method /><comment /></metabolite><metabolite><id>917</id><name>5-Hydroxytryptophan</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>905</id><name>Aromatic L-amino acid decarboxylase</name><specimen>liver</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1885</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>912</id><name>Dopamine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1413</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>100.00</min><max>209.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment>day 1-7</comment></metabolite><metabolite><id>1609</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1844</id><name>D-Glucose</name><specimen>urine</specimen><value>increased</value><min>76.00</min><max>810.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>47</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adolescence</age><method /><comment>fasted</comment></metabolite><metabolite><id>281</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment>fasted</comment></metabolite><metabolite><id>282</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.30</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment>fasted</comment></metabolite><metabolite><id>280</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>1.10</min><max>3.30</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>283</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.20</min><max>3.30</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, 1 day</comment></metabolite><metabolite><id>46</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.80</min><max>5.00</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, &gt;1 day</comment></metabolite><metabolite><id>399</id><name>D-Glucose</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.70</min><max>3.70</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1134</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>2.70</min><max>4.50</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1135</id><name>D-Glucose</name><specimen>plasma</specimen><value>increased</value><min>3.00</min><max>4.30</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>490</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>333</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>334</id><name>D-Glucose</name><specimen>blood</specimen><value>increased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>906</id><name>Dopamine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit /><age>no data</age><method /><comment /></metabolite><metabolite><id>913</id><name>Dopamine</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1556</id><name>N-Acetyltyrosine</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>69</id><name>N-Acetyltyrosine</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1383</id><name>N-Acetyltyrosine</name><specimen>urine</specimen><value>normal/inc</value><min>    </min><max>6.40</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1384</id><name>N-Acetyltyrosine</name><specimen>urine</specimen><value>normal/inc</value><min>    </min><max>781.00</max><unit>mmol/mol creatinine</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>909</id><name>S-Adenosylmethionine</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit /><age>no data</age><method /><comment /></metabolite><metabolite><id>2012</id><name>Vanillactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite></Metabolites><Literatures><literature><id>6980</id><title>Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook</title><author>Himmelreich N,</author><journal>Mol Genet Metab</journal><year>2019</year><book /><volume>127</volume><number>1</number><pages>12-22</pages><co_aut>et al.</co_aut></literature><literature><id>7226</id><title>[Clinical and genetic analysis of two pedigrees affected with aromatic L-amino acid decarboxylase deficiency]</title><author>Wang Y,</author><journal>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</journal><year>2019</year><book /><volume>36</volume><number>11</number><pages>1085-1089</pages><co_aut>et al.</co_aut></literature><literature><id>7227</id><title>Gene therapy improves brain white matter in aromatic l-amino acid decarboxylase deficiency</title><author>Tseng CH,</author><journal>Ann Neurol</journal><year>2019</year><book /><volume>85</volume><number>5</number><pages>644-652</pages><co_aut>et al.</co_aut></literature><literature><id>7228</id><title>A review of aromatic l-amino acid decarboxylase (AADC) deficiency in Taiwan</title><author>Lee NC,</author><journal>Am J Med Genet C Semin Med Genet</journal><year>2019</year><book /><volume>181</volume><number>2</number><pages>226-229</pages><co_aut>Chien YH, Hwu WL</co_aut></literature><literature><id>7229</id><title>A novel DDC gene deletion mutation in two Chinese mainland siblings with aromatic l-amino acid decarboxylase deficiency</title><author>Dai L,</author><journal>Brain Dev</journal><year>2019</year><book /><volume>41</volume><number>2</number><pages>205-209</pages><co_aut>Ding C, Fang F</co_aut></literature><literature><id>6984</id><title>Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R34</title><author>Montioli R,</author><journal>IUBMB Life</journal><year>2018</year><book /><volume>70</volume><number>3</number><pages>215-223</pages><co_aut>et al.</co_aut></literature><literature><id>4299</id><title>Microstructural changes of brain in patients with aromatic L-amino acid decarboxylase deficiency</title><author>Lee WT,</author><journal>Hum Brain Mapp</journal><year>2017</year><book /><volume>38</volume><number>3</number><pages>1532-1540</pages><co_aut>et al.</co_aut></literature><literature><id>4300</id><title>Simultaneous measurement of monoamine metabolites and 5-methyltetrahydrofolate in the cerebrospinal fluid of children</title><author>Akiyama T,</author><journal>Clin Chim Acta</journal><year>2017</year><book /><volume>465</volume><number>0</number><pages>5-10</pages><co_aut>et al.</co_aut></literature><literature><id>4301</id><title>Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency</title><author>Wassenberg T,</author><journal>Orphanet J Rare Dis</journal><year>2017</year><book /><volume>12</volume><number>1</number><pages>12</pages><co_aut>et al.</co_aut></literature><literature><id>4302</id><title>Chronic Diarrhea in L-Amino Acid Decarboxylase (AADC) Deficiency: A Prominent Clinical Finding Among a Series of Ten French Pat</title><author>Spitz MA,</author><journal>JIMD Rep</journal><year>2017</year><book /><volume>31</volume><number>0</number><pages>85-93</pages><co_aut>et al.</co_aut></literature><literature><id>4303</id><title>A female case of aromatic l-amino acid decarboxylase deficiency responsive to MAO-B inhibition</title><author>Kojima K,</author><journal>Brain Dev</journal><year>2016</year><book /><volume>38</volume><number>10</number><pages>959-963</pages><co_aut>et al.</co_aut></literature><literature><id>4304</id><title>The novel R347g pathogenic mutation of aromatic amino acid decarboxylase provides additional molecular insights into enzyme cat</title><author>Montioli R,</author><journal>Biochim Biophys Acta</journal><year>2016</year><book /><volume>1864</volume><number>6</number><pages>676-682</pages><co_aut>et al.</co_aut></literature><literature><id>3655</id><title>Aromatic L-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma.</title><author>Atwal PS,</author><journal>Mol Genet Metab</journal><year>2015</year><book /><volume>115</volume><number>2</number><pages>91-94</pages><co_aut>et al.</co_aut></literature><literature><id>3656</id><title>Report of two never treated adult sisters with aromatic L-amino Acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?</title><author>Leuzzi V,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>15</volume><number>0</number><pages>39-45</pages><co_aut>et al.</co_aut></literature><literature><id>4305</id><title>Syndromic intellectual disability: a new phenotype caused by an aromatic amino acid decarboxylase gene (DDC) variant</title><author>Graziano C,</author><journal>Gene</journal><year>2015</year><book /><volume>559</volume><number>2</number><pages>144-148</pages><co_aut>et al.</co_aut></literature><literature><id>3657</id><title>A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanism</title><author>Montioli R,</author><journal>Hum Mol Genet</journal><year>2014</year><book /><volume>23</volume><number>20</number><pages>5429-5440</pages><co_aut>et al.</co_aut></literature><literature><id>3658</id><title>Diagnosis of aromatic L-amino acid decarboxylase deficiency by measuring 3-O-methyldopa concentrations in dried blood spots</title><author>Chen PW,</author><journal>Clin Chim Acta</journal><year>2014</year><book /><volume>431</volume><number>0</number><pages>19-22</pages><co_aut>et al.</co_aut></literature><literature><id>3659</id><title>A rare cause of severe diarrhoea diagnosed by urine metabolic screening: aromatic L-amino acid decarboxylase deficiency.</title><author>Lee LK,</author><journal>Hong Kong Med J</journal><year>2014</year><book /><volume>20</volume><number>2</number><pages>161-164</pages><co_aut>et al.</co_aut></literature><literature><id>3660</id><title>Aromatic amino Acid decarboxylase deficiency not responding to pyridoxine and bromocriptine therapy: case report and review of response to treatment</title><author>Alfadhel M,</author><journal>J Cent Nerv Syst Dis</journal><year>2014</year><book /><volume>6</volume><number>0</number><pages>1-5</pages><co_aut>Kattan R</co_aut></literature><literature><id>4298</id><title>Non-invasive urinary screening for aromatic L-amino acid decarboxylase deficiency in high-prevalence areas: a pilot study</title><author>Lee HC,</author><journal>Clin Chim Acta</journal><year>2012</year><book /><volume>413</volume><number>1</number><pages>126-130</pages><co_aut>et al.</co_aut></literature><literature><id>2892</id><title>Abnormal glucose metabolism in aromatic l-amino acid decarboxylase deficiency</title><author>Ide S</author><journal>Brain Dev</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2893</id><title>A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency</title><author>Allen GF</author><journal>Mol Genet Metab</journal><year>2009</year><book /><volume>97</volume><number>1</number><pages>6-14</pages><co_aut>Land JM, Heales SJ</co_aut></literature><literature><id>2894</id><title>Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up</title><author>Manegold C</author><journal>J Inherit Metab Dis</journal><year>2009</year><book /><volume>32</volume><number>3</number><pages>371-380</pages><co_aut>et al.</co_aut></literature><literature><id>7232</id><title>Aromatic l-aminoacid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis&lt;/</title><author>Abdenur JE;</author><journal>Mol Genet Metab</journal><year>2006</year><book /><volume>87</volume><number>1</number><pages>48-53</pages><co_aut>et al.</co_aut></literature><literature><id>1648</id><title>Levodopa-responsive aromatic L-amino acid decarboxylase deficiency</title><author>Chang YT</author><journal>Ann Neurol</journal><year>2004</year><book /><volume>55</volume><number>3</number><pages>435-438</pages><co_aut>et al.</co_aut></literature><literature><id>1789</id><title>Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis</title><author>Pons R</author><journal>Neurology</journal><year>2004</year><book /><volume>62</volume><number>7</number><pages>1058-1065</pages><co_aut>Ford B, Chiriboga CA, Clayton PT, Hinton V, Hyland K, Sharma R, De Vivo DC</co_aut></literature><literature><id>1240</id><title>Dopa decarboxylase (Ddc) affects variation in Drosophila longevity</title><author>De Luca M</author><journal>Nat Genet</journal><year>2003</year><book /><volume>34</volume><number>4</number><pages>429-433</pages><co_aut>et al.</co_aut></literature><literature><id>1649</id><title>Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes</title><author>Swoboda KJ</author><journal>Ann Neurol</journal><year>2003</year><book /><volume>54</volume><number>6</number><pages>49-55</pages><co_aut>et al.</co_aut></literature><literature><id>1651</id><title>Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different</title><author>Fiumara A</author><journal>Neuropediatrics</journal><year>2002</year><book /><volume>33</volume><number>4</number><pages>203-208</pages><co_aut>et al.</co_aut></literature><literature><id>1081</id><title>Pathobiochemical implications of hyperdopaminuria in patients with aromatic L-amino acid decarboxylase deficiency</title><author>Abeling NGGM</author><journal>J Inherit Metab Dis</journal><year>2000</year><book /><volume>23</volume><number>0</number><pages>325-328</pages><co_aut>et al.</co_aut></literature><literature><id>1079</id><title>Clinical and therapeutic observations in aromatic L-amino acid decarboxylase deficiency</title><author>Swoboda KJ</author><journal>Neurology</journal><year>1999</year><book /><volume>53</volume><number>0</number><pages>1205-1211</pages><co_aut>et al.</co_aut></literature><literature><id>961</id><title>Aromatic L-amino acid decarboxylase deficiency: a new case with a mild clinical presentation and unexpected laboratory findings&lt;</title><author>Abeling NGGM</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>0</number><pages>240-242</pages><co_aut>et al.</co_aut></literature><literature><id>1080</id><title>Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family</title><author>Maller A</author><journal>J Child Neurol</journal><year>1997</year><book /><volume>12</volume><number>0</number><pages>349-354</pages><co_aut>et al.</co_aut></literature><literature><id>247</id><title>Encephalopathie bei einem Defekt im Metabolismus der biogenen Amine</title><author>Korenke GC</author><journal>10. Jahrestagung der APS in Fulda</journal><year>1996</year><book>8.-10.2.96</book><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>690</id><title>Disorders of neurotransmitter metabolism</title><author>Hyland K</author><journal>Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman &amp; Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>79-98</pages><co_aut>et al.</co_aut></literature><literature><id>244</id><title>Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransm</title><author>Hyland K</author><journal>Neurology</journal><year>1992</year><book /><volume>42</volume><number>10</number><pages>1980-1988</pages><co_aut>et al.</co_aut></literature><literature><id>245</id><title>Aromatic L-amino acid decarboxylase deficiency: diagnostic methology</title><author>Hyland K</author><journal>Clin Chem</journal><year>1992</year><book /><volume>38</volume><number>12</number><pages>2405-2410</pages><co_aut>Clayton PT</co_aut></literature><literature><id>246</id><title>Localisation of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13--</title><author>Craig SP</author><journal>Cytogenet Cell Genet</journal><year>1992</year><book /><volume>61</volume><number>2</number><pages>114-116</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>